Corrigendum to "Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer" [Cancer Genetics Volumes 276-277, August 2023, Pages 48-59].

Our study depicted the stemness landscapes of prostate cancer and characterized two subclusters with diverse prognoses and tumor immune microenvironments. A stemness-risk signature was developed and demonstrated prospective implications in predicting prognosis and precision medicine.